Lv6
1810 积分 2021-03-22 加入
First-line osimertinib compared to earlier generation TKIs in advanced EGFR-mutant NSCLC: A real-world survival analysis
11小时前
已完结
Dynamic ctDNA informs whole-course postoperative precise management of NSCLC (LUNGCA study)
17小时前
已完结
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
2天前
已完结
Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non-Small Cell Lung Cancer
27天前
已完结
Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
1个月前
已完结
Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?
1个月前
已完结
A Prospective Phase II Trial of First-Line Osimertinib for Patients With EGFR Mutation-Positive NSCLC and Poor Performance Status (OPEN/TORG2040)
1个月前
已完结
Pulmonary vein thrombosis: Clinical presentation and outcomes
1个月前
已完结
Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective study
2个月前
已完结
Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective study
2个月前
已完结
皖公网安备34019202002308
